Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free RTW Stock Alerts

RTW Biotech Opportunities (RTW) Competitors

RTW Biotech Opportunities logo
GBX 2.53 -0.01 (-0.47%)
As of 12:08 PM Eastern
Compare

RTW vs. VNC, SDV, EGT, VSL, and RSE

Should you buy RTW Biotech Opportunities stock or one of its competitors? RTW Biotech Opportunities's main competitors and comparable companies include Ventus VCT 2 C (VNC), Chelverton UK Dividend Trust (SDV), European Green Transition Plc O (EGT), VPC Specialty Lending Investments (VSL), and Riverstone Energy (RSE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does RTW Biotech Opportunities compare to Ventus VCT 2 C?

Ventus VCT 2 C (LON:VNC) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

RTW Biotech Opportunities has a net margin of 158.61% compared to Ventus VCT 2 C's net margin of 0.00%. RTW Biotech Opportunities' return on equity of 36.01% beat Ventus VCT 2 C's return on equity.

Company Net Margins Return on Equity Return on Assets
Ventus VCT 2 CN/A N/A N/A
RTW Biotech Opportunities 158.61%36.01%-0.47%

In the previous week, Ventus VCT 2 C's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
Ventus VCT 2 C Neutral
RTW Biotech Opportunities Neutral

RTW Biotech Opportunities has higher revenue and earnings than Ventus VCT 2 C. Ventus VCT 2 C is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ventus VCT 2 C£9.47M0.00N/A£21.20N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

2.8% of RTW Biotech Opportunities shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

RTW Biotech Opportunities beats Ventus VCT 2 C on 6 of the 8 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Chelverton UK Dividend Trust?

RTW Biotech Opportunities (LON:RTW) and Chelverton UK Dividend Trust (LON:SDV) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

RTW Biotech Opportunities has a net margin of 158.61% compared to Chelverton UK Dividend Trust's net margin of 86.83%. RTW Biotech Opportunities' return on equity of 36.01% beat Chelverton UK Dividend Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities158.61% 36.01% -0.47%
Chelverton UK Dividend Trust 86.83%15.15%0.90%

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled Chelverton UK Dividend Trust'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
Chelverton UK Dividend Trust Neutral

2.8% of RTW Biotech Opportunities shares are owned by institutional investors. Comparatively, 1.9% of Chelverton UK Dividend Trust shares are owned by institutional investors. 0.6% of RTW Biotech Opportunities shares are owned by insiders. Comparatively, 1.5% of Chelverton UK Dividend Trust shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

RTW Biotech Opportunities has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, Chelverton UK Dividend Trust has a beta of 0.721, suggesting that its stock price is 28% less volatile than the broader market.

RTW Biotech Opportunities has higher revenue and earnings than Chelverton UK Dividend Trust. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than Chelverton UK Dividend Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
Chelverton UK Dividend Trust£5.33M5.97£8.87M£21.906.47

Summary

RTW Biotech Opportunities beats Chelverton UK Dividend Trust on 7 of the 11 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to European Green Transition Plc O?

European Green Transition Plc O (LON:EGT) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

In the previous week, European Green Transition Plc O's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
European Green Transition Plc O Neutral
RTW Biotech Opportunities Neutral

23.0% of European Green Transition Plc O shares are held by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are held by institutional investors. 14.0% of European Green Transition Plc O shares are held by company insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

RTW Biotech Opportunities has higher revenue and earnings than European Green Transition Plc O. European Green Transition Plc O is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
European Green Transition Plc ON/AN/A-£709.49K-£0.87N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

European Green Transition Plc O has a beta of 1.229, meaning that its stock price is 23% more volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

RTW Biotech Opportunities has a net margin of 158.61% compared to European Green Transition Plc O's net margin of 0.00%. RTW Biotech Opportunities' return on equity of 36.01% beat European Green Transition Plc O's return on equity.

Company Net Margins Return on Equity Return on Assets
European Green Transition Plc ON/A -27.93% N/A
RTW Biotech Opportunities 158.61%36.01%-0.47%

Summary

RTW Biotech Opportunities beats European Green Transition Plc O on 6 of the 10 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to VPC Specialty Lending Investments?

VPC Specialty Lending Investments (LON:VSL) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

RTW Biotech Opportunities has a net margin of 158.61% compared to VPC Specialty Lending Investments' net margin of 108.11%. RTW Biotech Opportunities' return on equity of 36.01% beat VPC Specialty Lending Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
VPC Specialty Lending Investments108.11% -46.94% -3.93%
RTW Biotech Opportunities 158.61%36.01%-0.47%

VPC Specialty Lending Investments has a beta of 0.30362844, indicating that its share price is 70% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

RTW Biotech Opportunities has higher revenue and earnings than VPC Specialty Lending Investments. VPC Specialty Lending Investments is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VPC Specialty Lending Investments-£31.41M-0.97-£31.27M-£11.87N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

22.1% of VPC Specialty Lending Investments shares are held by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are held by institutional investors. 0.3% of VPC Specialty Lending Investments shares are held by company insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, VPC Specialty Lending Investments' average media sentiment score of 0.67 beat RTW Biotech Opportunities' score of 0.00 indicating that VPC Specialty Lending Investments is being referred to more favorably in the media.

Company Overall Sentiment
VPC Specialty Lending Investments Positive
RTW Biotech Opportunities Neutral

Summary

RTW Biotech Opportunities beats VPC Specialty Lending Investments on 10 of the 12 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Riverstone Energy?

Riverstone Energy (LON:RSE) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

RTW Biotech Opportunities has a net margin of 158.61% compared to Riverstone Energy's net margin of -1.67%. RTW Biotech Opportunities' return on equity of 36.01% beat Riverstone Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Riverstone Energy-1.67% -3.23% -0.22%
RTW Biotech Opportunities 158.61%36.01%-0.47%

RTW Biotech Opportunities has higher revenue and earnings than Riverstone Energy. Riverstone Energy is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Riverstone Energy£31.65M0.89£78.63M-£2.17N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

6.0% of Riverstone Energy shares are owned by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are owned by institutional investors. 66.9% of Riverstone Energy shares are owned by company insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Riverstone Energy had 1 more articles in the media than RTW Biotech Opportunities. MarketBeat recorded 1 mentions for Riverstone Energy and 0 mentions for RTW Biotech Opportunities. Riverstone Energy's average media sentiment score of 0.57 beat RTW Biotech Opportunities' score of 0.00 indicating that Riverstone Energy is being referred to more favorably in the media.

Company Overall Sentiment
Riverstone Energy Positive
RTW Biotech Opportunities Neutral

Riverstone Energy has a beta of 0.14201292, meaning that its stock price is 86% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

Summary

RTW Biotech Opportunities beats Riverstone Energy on 7 of the 13 factors compared between the two stocks.

Get RTW Biotech Opportunities News Delivered to You Automatically

Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RTW vs. The Competition

Export
MetricRTW Biotech OpportunitiesCapital Markets IndustryFinance SectorLON Exchange
Market Cap£8.16M£5.70B£14.04B£2.92B
Dividend YieldN/A7.40%5.89%6.17%
P/E Ratio0.0432.2826.58367.27
Price / Sales0.031,273.77524.7683,460.67
Price / Cash0.3248.3338.5027.89
Price / Book0.012.142.197.12
Net Income£14.09B£417.46M£1.31B£5.89B
7 Day Performance-1.25%0.81%1.37%0.74%
1 Month Performance4.03%2.36%2.98%3.13%
1 Year Performance80.57%7.76%11.65%22.34%

RTW Biotech Opportunities Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RTW
RTW Biotech Opportunities
N/AGBX 2.53
-0.5%		N/A+81.4%£8.16M£250.89M0.044,971
VNC
Ventus VCT 2 C
N/AN/AN/AN/A£32.58M£9.47M4.08N/A
SDV
Chelverton UK Dividend Trust
N/AGBX 141.84
-0.6%		N/A+1.2%£31.84M£5.33M6.48N/A
EGT
European Green Transition Plc O
N/AGBX 11.50
+1.1%		N/A+88.9%£31.01MN/AN/AN/A
VSL
VPC Specialty Lending Investments
N/AGBX 10.49
+1.4%		N/A-40.0%£29.20M-£31.41MN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:RTW) was last updated on 8/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel